当前位置： SCI文献检索 > Hepatology International期刊下所有文献 > End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients.

End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients.

Abstract：

BACKGROUND AND AIMS:Status 1A patients are prioritized over end-stage liver disease (ESLD) for liver transplantation (LT). ESLD patients with high MELD may have higher waitlist mortality than Status 1A patients, and may require LT more urgently. METHODS:Using United Network for Organ Sharing registry data, we retrospectively evaluated LT waitlist mortality and probability of LT between adults in the United States with Status 1A or ESLD with MELD >30 listed for LT from 2003-2013. Overall waitlist mortality and probability of LT were evaluated with Kaplan-Meier and multivariate logistic regression models. RESULTS:From 2003-2013, 15,049 ESLD patients with MELD >30 and 3049 Status 1A patients were listed for LT. While overall 14-day waitlist survival decreased with increasing MELD score among ESLD patients (54.0 % for MELD 31-35; 37.1 % for MELD 36-40; 27.5 % for MELD >40), overall survival at 14 days was significantly lower among Status 1A (14.4 %). Compared to Status 1A, ESLD patients with MELD >40 had significantly higher 14-day waitlist mortality (OR 1.92; 95 % CI 1.56-2.36; p < 0.001), whereas ESLD patients with MELD 36-40 had a non-significant trend towards higher waitlist mortality (OR 1.16; 95 % CI 0.93-1.45; p = 0.181). No difference in probability of LT within 14 days was observed between ESLD with MELD >40 and Status 1A (p = 0.89). ESLD patients with MELD >40 had higher post-LT survival compared to Status 1A on multivariate regression modeling (HR 0.80; 95 % CI 0.66-0.96; p < 0.02). CONCLUSION:Among adults in the United States awaiting LT, ESLD patients with MELD >40 have significantly higher waitlist mortality, but similar probability of receiving LT compared to Status 1A patients.

journal_name

Hepatol Int

journal_title

Hepatology international

authors

Ahn J,Bhuket T,Mosadeghi S,Frenette C,Liu B,Wong RJ

doi

10.1007/s12072-016-9735-4

subject

Has Abstract

pub_date

2016-09-01 00:00:00

pages

838-46

issue

5

eissn

1936-0533

issn

1936-0541

pii

10.1007/s12072-016-9735-4

journal_volume

10

pub_type

杂志文章

相关文献

Hepatology International文献大全
  • New drugs for NAFLD: lessons from basic models to the clinic.

    abstract：:The term nonalcoholic fatty liver disease (NAFLD) comprises a spectrum of increasingly harmful conditions ranging from nonalcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH) to liver fibrosis and end-stage cirrhosis. NAFLD is the currently most common form of chronic liver disease in both adults and ch...

    journal_title：Hepatology international

    pub_type： 杂志文章,评审

    doi：10.1007/s12072-019-10001-4

    authors： Reimer KC,Wree A,Roderburg C,Tacke F

    更新日期：2020-01-01 00:00:00

  • Asparaginase-induced hepatotoxicity: rapid development of cholestasis and hepatic steatosis.

    abstract：BACKGROUND:L-Asparaginase is a bacterial enzyme used in the treatment of acute lymphoblastic leukemia. In the ongoing U.S. Drug-Induced Liver Injury Network (DILIN) prospective study, standard and pegylated asparaginase were the most frequent cause of liver injury with jaundice among anti-cancer agents (8 of 40: 20%). ...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-019-09971-2

    authors： Kamal N,Koh C,Samala N,Fontana RJ,Stolz A,Durazo F,Hayashi PH,Phillips E,Wang T,Hoofnagle JH,Drug-Induced Liver Injury Network.

    更新日期：2019-09-01 00:00:00

  • Hepatocellular adenoma: what is new in 2008.

    abstract：:Patients (85%) with hepatocellular adenoma (HCA) are women taking oral contraceptives. They can be divided into four subgroups according to their genotype/phenotype features. (1) Hepatocyte nuclear factor 1alpha (HNF1alpha) biallelic somatic mutations are observed in 35% of the HCA cases. It occurs in almost all cases...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-008-9075-0

    authors： Bioulac-Sage P,Laumonier H,Laurent C,Zucman-Rossi J,Balabaud C

    更新日期：2008-09-01 00:00:00

  • Prognostic analysis of pulmonary metastases from hepatocellular carcinoma.

    abstract：PURPOSE:To analyze the prognostic factors for the patients with lung metastases from hepatocellular carcinoma (HCC). METHODS AND MATERIALS:One hundred and five patients with lung metastases from HCC were analyzed retrospectively. We analyzed the impact factors, including the gender, age, liver function, serum AFP and ...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-008-9052-7

    authors： Zhang SM,Zeng ZC,Tang ZY,Sun J,Cheng JM,Liu R,Wang P,Zhang BH

    更新日期：2008-06-01 00:00:00

  • A comparison of 4-year entecavir efficacy in nucleos(t)ide analog-naïve and -experienced adult Taiwanese chronic hepatitis B patients.

    abstract：PURPOSE:To compare the efficacy of entecavir (ETV) monotherapy up to 4 years in nucleos(t)ide analog (NA)-experienced and -naïve subjects. METHODS:One hundred sixty NA-experienced and 282 naïve chronic hepatitis B patients who were treated with ETV were enrolled. Of the 160 NA-experienced patients, 49 had prior lamivu...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-013-9440-5

    authors： Chen CH,Hu TH,Hung CH,Lu SN,Wang JH,Chang MH,Changchien CS,Lee CM

    更新日期：2013-07-01 00:00:00

  • HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma.

    abstract：BACKGROUND:Sorafenib significantly improves survival in patients with advanced hepatocellular carcinoma (HCC). This phase IV study assessed sorafenib efficacy/safety in Taiwanese patients with advanced HCC and Child-Pugh A status. METHODS:All patients received 400 mg sorafenib BID. Safety, efficacy, sorafenib pharmaco...

    journal_title：Hepatology international

    pub_type： 杂志文章,多中心研究,随机对照试验

    doi：10.1007/s12072-016-9774-x

    authors： Lin SM,Lu SN,Chen PT,Jeng LB,Chen SC,Hu CT,Yang SS,Le Berre MA,Liu X,Mitchell DY,Prins K,Grevel J,Peña CA,Meinhardt G

    更新日期：2017-03-01 00:00:00

  • Existence of cancer stem cells in hepatocellular carcinoma: myth or reality?

    abstract：:The cancer stem cell (CSC) hypothesis has been disproved in many cancers. CSCs may exist in blood cancer, while many epithelial cancers may not have CSCs but tumor-initiating cells (TICs). Several independent studies have provided strong evidence for existence of CSCs in brain, skin, and colon cancers (Mani et al. in ...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-016-9777-7

    authors： Machida K

    更新日期：2017-03-01 00:00:00

  • Cirrhotic cardiomyopathy.

    abstract：:Cirrhotic cardiomyopathy is a recently recognized condition in cirrhosis consisting of systolic incompetence under condition of stress, diastolic dysfunction related to altered diastolic relaxation, and electrophysiological abnormalities in the absence of any known cardiac disease. It can be diagnosed by using a combi...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-008-9109-7

    authors： Wong F

    更新日期：2009-03-01 00:00:00

  • Usefulness of multi-detector helical CT with multiplanar reconstruction for depicting the duodenal varices with multiple collateral shunt vessels.

    abstract：:Duodenal varices are a rare complication in patients with portal hypertension. Bleeding from duodenal varices often results in a severe prognosis. Diagnosis of the disease is usually based on findings obtained by endoscopy or angiography. However, it occasionally fails to detect the lesion and demonstrate its porto-sy...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-010-9191-5

    authors： Yoshida S,Watabe H,Akahane M,Kyoden Y,Ishikawa H,Yamada A,Sugimoto T,Ohta M,Ogura K,Yamaji Y,Ohtomo K,Kokudo N,Koike K,Omata M

    更新日期：2010-07-24 00:00:00

  • Effect of hepatitis B surface antibody in patients with core antibody-positive liver transplantation: a systematic review and meta-analysis.

    abstract：BACKGROUND AND AIM:There is an increased awareness of de novo hepatitis B virus (HBV) infection (DNH) in hepatitis B surface antigen (HBsAg)-negative recipients receiving hepatitis B core antibody (HBcAb)-positive liver organ. Whether hepatitis B surface antibody (HBsAb) has positive result on preventing the occurrence...

    journal_title：Hepatology international

    pub_type： 杂志文章,meta分析

    doi：10.1007/s12072-020-10021-5

    authors： Yang Y,Huang A,Zhao Y

    更新日期：2020-03-01 00:00:00

  • Predictors of outcome in acute-on-chronic liver failure in children.

    abstract：BACKGROUND AND AIMS:Acute-on-chronic liver failure (ACLF) is associated with a high mortality rate in the absence of liver transplantation. There is limited data on predictors of survival in ACLF in children. Therefore, we prospectively studied the predictors of outcome of ACLF in children. METHODS:A prospective evalu...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-010-9217-z

    authors： Lal J,Thapa BR,Rawal P,Ratho RK,Singh K

    更新日期：2011-06-01 00:00:00

  • Hepatitis B reactivation after chemotherapy: two decades of clinical research.

    abstract：:Hepatitis due to hepatitis B virus reactivation after cytotoxic or immunosuppressive therapy is a serious cause of liver-related morbidity and mortality. With the characterization of the underlying pathogenesis, much progress in the management of this important clinical problem has been made in the past 2 decades. By ...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-008-9056-3

    authors： Lau GK

    更新日期：2008-06-01 00:00:00

  • C1QTNF1-AS1 regulates the occurrence and development of hepatocellular carcinoma by regulating miR-221-3p/SOCS3.

    abstract：BACKGROUND:The aim of our study was to explore how C1QTNF1-AS1 regulated miR-221-3p/SOCS3 axis in human hepatocellular carcinoma (HCC). METHODS:Differentially expressed lncRNAs and genes were examined via RNA-seq. GO analysis and KEGG pathway enrichment analysis were carried out based on the function of dys-regulated ...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-019-09944-5

    authors： Li H,Zhang B,Ding M,Lu S,Zhou H,Sun D,Wu G,Gan X

    更新日期：2019-05-01 00:00:00

  • Genetic and epigenetic mechanisms of NASH.

    abstract：:Along with the obesity epidemic, the prevalence of nonalcoholic fatty liver disease (NAFLD) has increased exponentially. The histological disease spectrum of NAFLD ranges from bland fatty liver (hepatic steatosis), to the concomitant presence of inflammation and ballooning which defines nonalcoholic steatohepatitis (N...

    journal_title：Hepatology international

    pub_type： 杂志文章,评审

    doi：10.1007/s12072-015-9689-y

    authors： Eslam M,George J

    更新日期：2016-05-01 00:00:00

  • Live donor liver transplantation for alcoholic hepatitis.

    abstract：:Liver transplantation is a definitive therapy for patients with end-stage liver disease and cirrhosis, with improvement in survival and quality of life. Patients are carefully screened and selected for this modality of treatment to achieve maximum survival benefit. For example, a patient with hepatocellular carcinoma ...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-016-9770-1

    authors： Singal AK,Kamath PS

    更新日期：2017-01-01 00:00:00

  • Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis.

    abstract：BACKGROUND AND AIMS:Coronavirus disease 2019 (COVID-19) pandemic is ongoing. Except for lung injury, it is possible that COVID-19 patients develop liver injury. Thus, we conducted a systematic review and meta-analysis to explore the incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 ...

    journal_title：Hepatology international

    pub_type： 杂志文章,meta分析

    doi：10.1007/s12072-020-10074-6

    authors： Wu Y,Li H,Guo X,Yoshida EM,Mendez-Sanchez N,Levi Sandri GB,Teschke R,Romeiro FG,Shukla A,Qi X

    更新日期：2020-09-01 00:00:00

  • Feasibility of liver graft procurement with donor gallbladder preservation in living donor liver transplantation.

    abstract：OBJECTIVE:Cholecystectomy is routinely performed at most transplant centers during living donor liver transplantation (LDLT). This study was performed to evaluate the feasibility of liver graft procurement with donor gallbladder preservation in LDLT. METHODS:Eighty-nine LDLTs (from June 2006 to Dec 2012) were retrospe...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-015-9628-y

    authors： Dong JH,Ye S,Duan WD,Ji WB,Liang YR

    更新日期：2015-10-01 00:00:00

  • Impact of viral hepatitis B status on outcomes of intrahepatic cholangiocarcinoma: a meta-analysis.

    abstract：BACKGROUND AND AIMS:To estimate the impact of viral hepatitis B status on outcomes of intrahepatic cholangiocarcinoma. METHODS:We searched Pubmed and Embase for original articles that evaluated the impact of hepatitis B virus infection on outcomes of intrahepatic cholangiocarcinoma. The present study was conducted to ...

    journal_title：Hepatology international

    pub_type： 杂志文章,meta分析,评审

    doi：10.1007/s12072-018-9881-y

    authors： Jeong S,Luo G,Wang ZH,Sha M,Chen L,Xia Q

    更新日期：2018-07-01 00:00:00

  • Pharmacologic prevention of variceal bleeding and rebleeding.

    abstract：BACKGROUND:Variceal bleeding is a major complication of portal hypertension, which is associated with significant mortality. Moreover, patients surviving a variceal bleeding episode have very high risk of rebleeding, which is associated with mortality as high as that of the first bleed. Because of this, prevention of b...

    journal_title：Hepatology international

    pub_type： 杂志文章,评审

    doi：10.1007/s12072-017-9833-y

    authors： Baiges A,Hernández-Gea V,Bosch J

    更新日期：2018-02-01 00:00:00

  • Viscoelastic test-based bleeding risk score reliably predicts coagulopathic bleeding in decompensated cirrhosis and ACLF patients.

    abstract：BACKGROUND AND AIMS:Coagulopathic bleeding risk prediction is challenging in decompensated cirrhosis (DC) by conventional assays. Viscoelastic tests (VETs) are likely to be more useful for assessing coagulation status in these patients. We investigated whether the VET (Sonoclot) parameters with fibrinogen could predict...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-020-10036-y

    authors： Bihari C,Patil A,Shasthry SM,Baweja S,Kumar G,Sarin SK

    更新日期：2020-07-01 00:00:00

  • Liver stiffness measurement in the risk assessment of hepatocellular carcinoma for patients with chronic hepatitis.

    abstract：BACKGROUND/AIMS:[corrected] The risk of hepatocellular carcinoma (HCC) increased with progression of hepatic fibrosis as assessed by liver stiffness measurement (LSM). This study used LSM to assess the risk of HCC presence in patients with chronic hepatitis. METHODS:The patients with liver tumor or chronic hepatitis i...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-010-9223-1

    authors： Kuo YH,Lu SN,Hung CH,Kee KM,Chen CH,Hu TH,Lee CM,Changchien CS,Wang JH

    更新日期：2010-10-08 00:00:00

  • Evidence of serologic activity in chronic hepatitis B after surface antigen (HBsAg) seroclearance documented by conventional HBsAg assay.

    abstract：BACKGROUND:Possible serologic activity after hepatitis B surface antigen (HBsAg) seroclearance documented by conventional assays in chronic hepatitis B (CHB) has not been thoroughly investigated. METHODS:We determined the levels of serum hepatitis B virus (HBV) DNA, hepatitis B core-related antigen (HBcrAg), and linea...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-012-9354-7

    authors： Seto WK,Tanaka Y,Wong DK,Lai CL,Shinkai N,Yuen JC,Tong T,Fung J,Hung IF,Yuen MF

    更新日期：2012-03-13 00:00:00

  • Survival advantage of primary liver transplantation for hepatocellular carcinoma within the up-to-7 criteria with microvascular invasion.

    abstract：PURPOSE:Microvascular invasion of hepatocellular carcinoma (HCC) is considered a poor prognostic factor of liver resection (LR) and liver transplantation (LT), but its significance for lesions within the up-to-7 criteria is unclear. This study investigated the survival benefit of primary LT against LR for HCC with micr...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-011-9318-3

    authors： Chan SC,Fan ST,Chok KS,Cheung TT,Chan AC,Fung JY,Poon RT,Lo CM

    更新日期：2011-10-21 00:00:00

  • Targeting incretin hormones and the ASK-1 pathway as therapeutic options in the treatment of non-alcoholic steatohepatitis.

    abstract：:Non-alcoholic fatty liver disease (NAFLD) is currently one of the leading forms of chronic liver disease, and its rising frequency worldwide has reached epidemic proportions. NAFLD, particularly its progressive variant NASH (non-alcoholic steatohepatitis), can lead to advanced fibrosis, cirrhosis, and HCC. The pathoph...

    journal_title：Hepatology international

    pub_type： 杂志文章,评审

    doi：10.1007/s12072-018-9854-1

    authors： Kovalic AJ,Satapathy SK,Chalasani N

    更新日期：2018-03-01 00:00:00

  • Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management.

    abstract：:Chronic hepatitis B virus (HBV) infection is endemic in the Asian-Pacific region, and reactivation of HBV post-cancer chemotherapy has become an emerging clinical challenge. Patients with detectable serum HBV DNA before chemotherapy and those receiving intensive chemotherapy are particularly at a risk of HBV reactivat...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-011-9279-6

    authors： Liu CJ,Chen PJ,Chen DS,Kao JH

    更新日期：2013-06-01 00:00:00

  • Management of primary sclerosing cholangitis and its complications: an algorithmic approach.

    abstract：:Primary sclerosing cholangitis (PSC) is a rare cholestatic liver disease, characterized by multiple strictures and dilatations of the intra- and extrahepatic bile ducts, leading to progressive liver fibrosis, in 10-15% cholangiocarcinoma, and ultimately end-stage liver disease. The pathogenesis is poorly understood, b...

    journal_title：Hepatology international

    pub_type： 杂志文章,评审

    doi：10.1007/s12072-020-10118-x

    authors： Prokopič M,Beuers U

    更新日期：2020-12-30 00:00:00

  • Spontaneous bacterial peritonitis from Salmonella: an unusual bacterium with unusual presentation.

    abstract：:Spontaneous bacterial peritonitis (SBP) is a common cause of morbidity and mortality in patients with advanced cirrhosis and portal hypertension. While gram-negative rods and Enterococcus species are the common offending organisms, Salmonella has also been recognized as a rare and atypical offending organism. Atypical...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-008-9087-9

    authors： Rajekar H,Wai CT,Lee KH,Wong SY,Tan KC

    更新日期：2008-09-01 00:00:00

  • Interferon gamma, interleukin-6, and -17a levels were correlated with minimal hepatic encephalopathy in HBV patients.

    abstract：BACKGROUND AND OBJECTIVE:Cytokines have been reported to be involved in the cirrhosis and hepatic encephalopathy (HE). Many aspects on the correlation between minimal HE (MHE) and cytokine levels were still unclear. METHODS:Two hundred eighty-nine HBV-infected cirrhotic patients were grouped: non MHE (n = 156), MHE (n...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-015-9610-8

    authors： Li W,Li N,Wang R,Li Q,Wu H

    更新日期：2015-04-01 00:00:00

  • Epigenetic histone modifications in a clinically relevant rat model of chronic ethanol-binge-mediated liver injury.

    abstract：PURPOSE:Ethanol binge augments liver injury after chronic ethanol consumption in humans, but the mechanism behind the enhanced liver injury by ethanol binge is not known. In this study we used a clinically relevant rat model in which liver injury is amplified by binge after chronic ethanol treatment and investigated th...

    journal_title：Hepatology international

    pub_type： 杂志文章

    doi：10.1007/s12072-014-9546-4

    authors： Aroor AR,Restrepo RJ,Kharbanda KK,Shukla SD

    更新日期：2014-09-01 00:00:00

  • Chinese guidelines on the management of ascites and its related complications in cirrhosis.

    abstract：:The Chinese Society of Hepatology developed the current guidelines for the Management of Ascites and Its Related Complications in Cirrhosis based on the published evidences and the panelists' consensus. The guidelines provided recommendations for the diagnosis and management of cirrhotic ascites emphasizing a step-wis...

    journal_title：Hepatology international

    pub_type： 社论,实务指引

    doi：10.1007/s12072-018-09923-2

    authors： Chinese Society of Hepatology, Chinese Medical Association.,Xu X,Duan Z,Ding H,Li W,Jia J,Wei L,Linghu E,Zhuang H

    更新日期：2019-01-01 00:00:00